Advertisement

Topics

Biota Inc Company Profile

20:22 EDT 25th September 2017 | BioPortfolio

Biota, Inc. is an early-stage drug discovery company focused on the discovery and development of new classes of anti-infective and anti-cancer drugs. The Company’s discovery platform is referred to as N•MAX and is initially focused on improving existing nucleoside drugs to create novel compounds

Location

2232 Rutherford Road
Carlsbad
California
92008
United States of America

Contact

Phone: 60.804.6980
Fax: 760.804.2740
Email: info@biota-inc.com


News Articles [3 Associated News Articles listed on BioPortfolio]

Mangrove Partners Agrees to Support Amended Transaction Between Nabi Biopharmaceuticals and Biota Holdings

NEW YORK, Sept. 19, 2012 /PRNewswire/ -- The Mangrove Partners Fund, L.P. ("Mangrove Partners"), one of the largest stockholders of Nabi Biopharmaceuticals (NasdaqGS: NABI), announced today that ...

Going with the flow: The forces that affect species' movements in a changing climate

(Hokkaido University) Scientists have developed a simple metric to capture the directional agreement between ocean currents and warming, revealing how ocean currents affect the range shift of marine b...

Global Copper Oxychloride Market Data Survey Report 2025 [Report Updated: 15082017] Prices from USD $1500

SummaryCopper Oxychloride is the chemical compound with the formula Cu2OH3Cl. It is often referred to as tribasic copper chloride TBCC, copper trihydroxyl chloride or copper hydroxychloride. It is a g...

Drugs and Medications [0 Results]

None

PubMed Articles [50 Associated PubMed Articles listed on BioPortfolio]

Five palaeobiological laws needed to understand the evolution of the living biota.

The foundations of several disciplines can be expressed as simple quantitative laws, for example, Newton's laws or the laws of thermodynamics. Here I present five laws derived from fossil data that de...

Detection of chemical warfare agent-related phenylarsenic compounds in marine biota samples by LC-HESI/MS/MS.

A new method has been developed to determine oxidation products of three chemical warfare agent (CWA) related phenylarsenic compounds from marine biota samples by a liquid chromatography-heated electr...

A dual pathways transfer model to account for changes in the radioactive caesium level in demersal and pelagic fish after the Fukushima Daï-ichi nuclear power plant accident.

The Fukushima Daï-ichi nuclear power plant (FDNPP) accident resulted in radioactive Cs being discharged into the local marine environment. While Cs bioaccumulates in biota and slowly depurates, the C...

Microplastics as vectors for environmental contaminants: Exploring sorption, desorption, and transfer to biota.

The occurrence and effects of microplastics (MPs) in the aquatic environment are receiving increasing attention. In addition to their possible direct adverse effects on biota, the potential role of MP...

DNA in a bottle-Rapid metabarcoding survey for early alerts of invasive species in ports.

Biota monitoring in ports is increasingly needed for biosecurity reasons and safeguarding marine biodiversity from biological invasion. Present and future international biosecurity directives can be a...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Safety, Tolerability and Pharmacokinetic Study of Biota-CS-8958

This study will look at the safety, tolerability and what the body does to CS-8958 given to 40 healthy volunteers 18-55 years old. CS-8958 is a dry-powder investigational drug that is brea...

Companies [6 Associated Companies listed on BioPortfolio]

Biota Holdings Limited

Biota is a leading anti-infective drug development company based in Melbourne Australia, with key expertise in respiratory diseases, particularly influenza. Biota developed the fi...

Biota Holdings Limited Australia

Biota's mission is to add shareholder value through the discovery and development of new pharmaceuticals for the management of infectious diseases and inflammation.

Biota Group

Biota initiated its activities in medical fields in 1970. Now we are providing support to to over 100 hospitals, clinics and medical centers by offering quality products at affordable prices. This end...

Biota Inc

Biota, Inc. is an early-stage drug discovery company focused on the discovery and development of new classes of anti-infective and anti-cancer drugs. The Company’s discovery platform is referred to ...

Xenome Ltd

Xenome Ltd. was established to mine the diverse therapeutic potential of Australia's terrestrial and marine biota, to create a deep pipeline of potential solutions for unmet chronic conditions includi...

More Information about "Biota Inc" on BioPortfolio

We have published hundreds of Biota Inc news stories on BioPortfolio along with dozens of Biota Inc Clinical Trials and PubMed Articles about Biota Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biota Inc Companies in our database. You can also find out about relevant Biota Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record